GlassScriptPhysician profile
Krishna Gunturu
NPI 1699881037
$36,779.07
in general payments reported to CMS, 2019-2025
20 companies · $15K in 2025
The $15K reported for 2025 was more than what 91% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $16.42 · 2021: $130 · 2022: $1,516 · 2023: $4,045 · 2024: $5,659 · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $22K · Travel and Lodging: $1,313 · Food and Beverage: $689 · Education: $22.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $22,470.00 |
| Travel and Lodging | $1,313.00 |
| Food and Beverage | $689.13 |
| Education | $22.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $8,795.47 | 2023-2025 | Opdivo |
| Astrazeneca Pharmaceuticals LP | $7,266.42 | 2020-2025 | Imfinzi, Tagrisso |
| Amgen INC. | $6,860.00 | 2025 | |
| Eisai INC. | $6,055.48 | 2019 | |
| Lilly USA, LLC | $4,552.89 | 2019 | |
| G1 Therapeutics, INC. | $1,500.00 | 2022 | |
| Daiichi Sankyo INC. | $1,350.00 | 2025 | |
| Seagen INC. | $130.00 | 2021 | |
| Springworks Therapeutics, INC. | $82.49 | 2025 | Ogsiveo |
| Genentech USA, INC. | $56.76 | 2024 | |
| Pfizer INC. | $49.98 | 2019-2025 | |
| Gilead Sciences, INC. | $33.30 | 2025 | Trodelvy |
| Tempus Ai, INC | $24.28 | 2025 | Xt Cdx |
| Janssen Pharmaceuticals, INC | $22.00 | 2024 | Rybrevant |
6 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Krishna Gunturu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.